Wrong, confidential information was withheld from the last 10-Q and was documented as such in the 10-Q. Today's SEC document approves the request Amarantus made to the SEC along with the 10-Q filing back in August.

Amarantus doesn't need protecting from this. Everything was done in the correct order. Request, then SEC approval. Let's not create problems where none exist.

Quote:

---

Amarantus Bioscience Holdings, Inc. submitted an application under Rule 24b-2 requesting confidential treatment for information it excluded from the Exhibits to a Form 10-Q filed on August 15, 2014.

Based on representations by Amarantus Bioscience Holdings, Inc. that this information qualifies as confidential commercial or financial information under the Freedom of Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined not to publicly disclose it. Accordingly, excluded information from the following exhibit(s) will not be released to the public for the time period(s) specified:

Exhibit 10.3 through January 10, 2016

For the Commission, by the Division of Corporation Finance, pursuant to delegated authority:

Brent J. Fields
Secretary

---